10X Genomics Inc vs Zscaler Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Zscaler Inc trades at $148.6 (market cap $24.23B). The key difference: Zscaler Inc is far larger — about 4.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Zscaler Inc nearer its low. Which is the better fit depends on your goals.
| TXG | ZS | |
|---|---|---|
Market Cap | $5.48B | $24.23B |
Sector | Health | Technology |
52-Week High | $45.80 | $336.27 |
52-Week Low | $11.34 | $118.05 |
Enterprise Value | $5.02B | $22.55B |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →